nodes	percent_of_prediction	percent_of_DWPC	metapath
Tadalafil—PDE5A—Theophylline—asthma	0.333	0.506	CbGbCtD
Tadalafil—CYP3A4—Fluticasone furoate—asthma	0.0259	0.0393	CbGbCtD
Tadalafil—CYP3A4—Budesonide—asthma	0.0231	0.035	CbGbCtD
Tadalafil—CYP3A4—Ciclesonide—asthma	0.0211	0.032	CbGbCtD
Tadalafil—CYP3A4—Indacaterol—asthma	0.0211	0.032	CbGbCtD
Tadalafil—CYP3A4—Salbutamol—asthma	0.0196	0.0298	CbGbCtD
Tadalafil—CYP3A4—Flunisolide—asthma	0.0196	0.0298	CbGbCtD
Tadalafil—CYP3A4—Salmeterol—asthma	0.0196	0.0298	CbGbCtD
Tadalafil—CYP3A4—Ipratropium bromide—asthma	0.0175	0.0266	CbGbCtD
Tadalafil—CYP3A4—Zileuton—asthma	0.0175	0.0266	CbGbCtD
Tadalafil—CYP3A4—Fluticasone Propionate—asthma	0.0167	0.0253	CbGbCtD
Tadalafil—CYP3A4—Zafirlukast—asthma	0.0154	0.0234	CbGbCtD
Tadalafil—CYP3A4—Tiotropium—asthma	0.0133	0.0201	CbGbCtD
Tadalafil—CYP3A4—Aminophylline—asthma	0.0127	0.0192	CbGbCtD
Tadalafil—CYP3A4—Theophylline—asthma	0.0119	0.0181	CbGbCtD
Tadalafil—CYP3A4—Montelukast—asthma	0.0113	0.0171	CbGbCtD
Tadalafil—CYP3A4—Loratadine—asthma	0.0113	0.0171	CbGbCtD
Tadalafil—CYP3A4—Methylprednisolone—asthma	0.0103	0.0157	CbGbCtD
Tadalafil—CYP3A4—Triamcinolone—asthma	0.00782	0.0119	CbGbCtD
Tadalafil—CYP3A4—Betamethasone—asthma	0.00671	0.0102	CbGbCtD
Tadalafil—CYP3A4—Prednisolone—asthma	0.00662	0.01	CbGbCtD
Tadalafil—CYP3A4—Hydrocortisone—asthma	0.00627	0.00952	CbGbCtD
Tadalafil—CYP3A4—Prednisone—asthma	0.00625	0.00948	CbGbCtD
Tadalafil—PDE11A—epithelium—asthma	0.00449	0.264	CbGeAlD
Tadalafil—CYP3A4—Dexamethasone—asthma	0.0039	0.00592	CbGbCtD
Tadalafil—PDE11A—adrenal gland—asthma	0.00326	0.191	CbGeAlD
Tadalafil—PDE5A—respiratory system—asthma	0.00205	0.12	CbGeAlD
Tadalafil—PDE5A—epithelium—asthma	0.00171	0.1	CbGeAlD
Tadalafil—PDE5A—smooth muscle tissue—asthma	0.00165	0.0966	CbGeAlD
Tadalafil—PDE5A—cardiovascular system—asthma	0.00157	0.0919	CbGeAlD
Tadalafil—PDE5A—adrenal gland—asthma	0.00124	0.0727	CbGeAlD
Tadalafil—PDE5A—lung—asthma	0.00109	0.0637	CbGeAlD
Tadalafil—PDE11A—Signaling by GPCR—HRH4—asthma	0.000266	0.00352	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—SERPINA1—asthma	0.000262	0.00348	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CSF2RB—asthma	0.00026	0.00345	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—TACR2—asthma	0.000255	0.00338	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CCR8—asthma	0.000255	0.00338	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—GATA3—asthma	0.00025	0.00332	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CCL17—asthma	0.00025	0.00331	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PDE4A—asthma	0.000245	0.00325	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—IL5—asthma	0.000237	0.00314	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CYSLTR1—asthma	0.00023	0.00304	CbGpPWpGaD
Tadalafil—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—asthma	0.000225	0.00298	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—NOS1—asthma	0.000223	0.00295	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—GATA3—asthma	0.000223	0.00295	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PDE4A—asthma	0.000223	0.00295	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—C5AR1—asthma	0.000222	0.00294	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—VIP—asthma	0.000222	0.00294	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—UTS2—asthma	0.000222	0.00294	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—IL3—asthma	0.000221	0.00292	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—HNMT—asthma	0.000218	0.00289	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CCR4—asthma	0.000213	0.00282	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—IL5—asthma	0.000211	0.0028	CbGpPWpGaD
Tadalafil—CYP3A4—Estrogen metabolism—GSTM1—asthma	0.000209	0.00277	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CYSLTR1—asthma	0.000209	0.00276	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—KNG1—asthma	0.000208	0.00276	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—IL2RB—asthma	0.000205	0.00271	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PDE4D—asthma	0.000203	0.00269	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—C5AR1—asthma	0.000201	0.00267	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CCL11—asthma	0.000201	0.00267	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—VIP—asthma	0.000201	0.00267	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—UTS2—asthma	0.000201	0.00267	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—NOS1—asthma	0.000199	0.00263	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—C3AR1—asthma	0.000199	0.00263	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—FCER2—asthma	0.000199	0.00263	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PDE4B—asthma	0.000198	0.00262	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—C5—asthma	0.000198	0.00262	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—TACR1—asthma	0.000198	0.00262	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—IL3—asthma	0.000197	0.00261	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CCR4—asthma	0.000193	0.00256	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CYSLTR2—asthma	0.000191	0.00253	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—IL2RB—asthma	0.000186	0.00246	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—ITPR1—asthma	0.000186	0.00246	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—KNG1—asthma	0.000185	0.00246	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PTGDR—asthma	0.000185	0.00245	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCL22—asthma	0.000185	0.00245	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—LTB4R—asthma	0.000185	0.00245	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PDE4D—asthma	0.000184	0.00244	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CCR3—asthma	0.000181	0.0024	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PDE4B—asthma	0.00018	0.00238	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—C5—asthma	0.00018	0.00238	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—TACR1—asthma	0.00018	0.00238	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—NPY—asthma	0.000176	0.00234	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PLA2G4A—asthma	0.000173	0.0023	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—CSF2—asthma	0.000171	0.00227	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—AGTR2—asthma	0.00017	0.00225	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—ITPR1—asthma	0.000165	0.00219	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CCR3—asthma	0.000164	0.00218	CbGpPWpGaD
Tadalafil—CYP3A4—Tryptophan metabolism—ALDH2—asthma	0.000163	0.00216	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—EDNRB—asthma	0.000163	0.00216	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—NPS—asthma	0.000161	0.00214	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—TAC1—asthma	0.000161	0.00214	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—NPY—asthma	0.00016	0.00212	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PPP2CA—asthma	0.00016	0.00212	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CXCR3—asthma	0.000158	0.0021	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HRH4—asthma	0.000157	0.00208	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NPSR1—asthma	0.000157	0.00208	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PMCH—asthma	0.000157	0.00208	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PTGDR2—asthma	0.000157	0.00208	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—IL2RA—asthma	0.000155	0.00205	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PLA2G4A—asthma	0.000155	0.00205	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—AGTR2—asthma	0.000154	0.00205	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CSF2RB—asthma	0.000154	0.00204	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—CSF2—asthma	0.000153	0.00203	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TACR2—asthma	0.000151	0.002	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCR8—asthma	0.000151	0.002	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—IL5—asthma	0.00015	0.00199	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PDGFB—asthma	0.000149	0.00198	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—EDNRB—asthma	0.000148	0.00196	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCL17—asthma	0.000148	0.00196	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—TAC1—asthma	0.000146	0.00194	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—NPS—asthma	0.000146	0.00194	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PLAU—asthma	0.000145	0.00192	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—CDK2—asthma	0.000145	0.00192	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—BDKRB2—asthma	0.000145	0.00192	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CXCR3—asthma	0.000144	0.0019	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PPP2CA—asthma	0.000142	0.00189	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—ADCY2—asthma	0.00014	0.00185	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—IL3—asthma	0.000139	0.00185	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—IL2RA—asthma	0.000138	0.00183	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—IL5—asthma	0.000136	0.0018	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—FN1—asthma	0.000135	0.00178	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—NOS2—asthma	0.000133	0.00176	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PDGFB—asthma	0.000133	0.00176	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—KIF3A—asthma	0.000132	0.00174	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PDE4A—asthma	0.000132	0.00174	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—KNG1—asthma	0.000132	0.00174	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—BDKRB2—asthma	0.000131	0.00174	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—AGTR1—asthma	0.000131	0.00173	CbGpPWpGaD
Tadalafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—asthma	0.000129	0.00171	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PLAU—asthma	0.000129	0.00171	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—CDK2—asthma	0.000129	0.00171	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CXCL10—asthma	0.000128	0.00169	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—ADCY2—asthma	0.000127	0.00168	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—IL3—asthma	0.000127	0.00168	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—ADRB2—asthma	0.000124	0.00164	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CYSLTR1—asthma	0.000123	0.00163	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—FN1—asthma	0.00012	0.00159	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—KNG1—asthma	0.000119	0.00158	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—C5AR1—asthma	0.000119	0.00158	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—UTS2—asthma	0.000119	0.00158	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCL11—asthma	0.000119	0.00158	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CMA1—asthma	0.000119	0.00158	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—VIP—asthma	0.000119	0.00158	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—AGTR1—asthma	0.000119	0.00157	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—NOS2—asthma	0.000118	0.00157	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—ITPR1—asthma	0.000117	0.00155	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CXCL10—asthma	0.000116	0.00154	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCR4—asthma	0.000114	0.00151	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—ADRB2—asthma	0.000113	0.00149	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—SERPINE1—asthma	0.000112	0.00148	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—STAT6—asthma	0.000112	0.00148	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—ALB—asthma	0.000112	0.00148	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—EDN1—asthma	0.000111	0.00147	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CCL5—asthma	0.00011	0.00146	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IL2RB—asthma	0.00011	0.00146	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PDE4D—asthma	0.000109	0.00144	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CSF2—asthma	0.000108	0.00144	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—RHOA—asthma	0.000108	0.00143	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—NOS3—asthma	0.000107	0.00142	CbGpPWpGaD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—asthma	0.000107	0.00142	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—ITPR1—asthma	0.000107	0.00141	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—C5—asthma	0.000106	0.00141	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PDE4B—asthma	0.000106	0.00141	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TACR1—asthma	0.000106	0.00141	CbGpPWpGaD
Tadalafil—CYP3A4—Tryptophan metabolism—CAT—asthma	0.000105	0.00139	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—EDN1—asthma	0.000101	0.00133	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CCL5—asthma	9.99e-05	0.00132	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—SERPINE1—asthma	9.98e-05	0.00132	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—ALB—asthma	9.96e-05	0.00132	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PLA2G4A—asthma	9.95e-05	0.00132	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CCR5—asthma	9.91e-05	0.00131	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CSF2—asthma	9.84e-05	0.0013	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—IL2RA—asthma	9.76e-05	0.00129	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCR3—asthma	9.7e-05	0.00129	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—C3—asthma	9.68e-05	0.00128	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—RHOA—asthma	9.62e-05	0.00128	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—NOS3—asthma	9.52e-05	0.00126	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NPY—asthma	9.45e-05	0.00125	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PPP2CA—asthma	9.16e-05	0.00121	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AGTR2—asthma	9.12e-05	0.00121	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—IL2—asthma	9.06e-05	0.0012	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CCR5—asthma	9e-05	0.00119	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—IL2RA—asthma	8.87e-05	0.00118	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—C3—asthma	8.79e-05	0.00117	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—EDNRB—asthma	8.73e-05	0.00116	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NPS—asthma	8.65e-05	0.00115	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TAC1—asthma	8.65e-05	0.00115	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CXCR3—asthma	8.48e-05	0.00112	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CYBA—asthma	8.21e-05	0.00109	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—IL2—asthma	8.07e-05	0.00107	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PARP1—asthma	8.04e-05	0.00107	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IL5—asthma	8.04e-05	0.00107	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—BDKRB2—asthma	7.75e-05	0.00103	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—POMC—asthma	7.74e-05	0.00103	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—VEGFA—asthma	7.7e-05	0.00102	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ADCY2—asthma	7.5e-05	0.000995	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IL3—asthma	7.48e-05	0.000991	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—TGFB1—asthma	7.07e-05	0.000937	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—KNG1—asthma	7.05e-05	0.000935	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—POMC—asthma	7.03e-05	0.000932	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AGTR1—asthma	7.01e-05	0.00093	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CCL2—asthma	6.88e-05	0.000912	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—VEGFA—asthma	6.86e-05	0.00091	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—IL6R—asthma	6.86e-05	0.000909	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CXCL10—asthma	6.85e-05	0.000908	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—RHOA—asthma	6.82e-05	0.000904	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NTRK1—asthma	6.72e-05	0.000891	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ADRB2—asthma	6.65e-05	0.000882	CbGpPWpGaD
Tadalafil—Eye disorder—Betamethasone—asthma	6.48e-05	0.000261	CcSEcCtD
Tadalafil—Eye disorder—Dexamethasone—asthma	6.48e-05	0.000261	CcSEcCtD
Tadalafil—Nausea—Formoterol—asthma	6.48e-05	0.00026	CcSEcCtD
Tadalafil—Nausea—Arformoterol—asthma	6.48e-05	0.00026	CcSEcCtD
Tadalafil—Angioedema—Hydrocortisone—asthma	6.46e-05	0.00026	CcSEcCtD
Tadalafil—Headache—Salbutamol—asthma	6.45e-05	0.000259	CcSEcCtD
Tadalafil—Back pain—Triamcinolone—asthma	6.43e-05	0.000259	CcSEcCtD
Tadalafil—Loss of consciousness—Prednisolone—asthma	6.36e-05	0.000256	CcSEcCtD
Tadalafil—Vertigo—Hydrocortisone—asthma	6.35e-05	0.000255	CcSEcCtD
Tadalafil—Nausea—Montelukast—asthma	6.34e-05	0.000255	CcSEcCtD
Tadalafil—Vomiting—Budesonide—asthma	6.34e-05	0.000255	CcSEcCtD
Tadalafil—Syncope—Hydrocortisone—asthma	6.34e-05	0.000255	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—TGFB1—asthma	6.3e-05	0.000835	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ITPR1—asthma	6.29e-05	0.000834	CbGpPWpGaD
Tadalafil—Angiopathy—Betamethasone—asthma	6.29e-05	0.000253	CcSEcCtD
Tadalafil—Angiopathy—Dexamethasone—asthma	6.29e-05	0.000253	CcSEcCtD
Tadalafil—Rash—Budesonide—asthma	6.29e-05	0.000253	CcSEcCtD
Tadalafil—Dermatitis—Budesonide—asthma	6.28e-05	0.000253	CcSEcCtD
Tadalafil—Convulsion—Prednisolone—asthma	6.27e-05	0.000252	CcSEcCtD
Tadalafil—Headache—Budesonide—asthma	6.25e-05	0.000251	CcSEcCtD
Tadalafil—Hypertension—Prednisolone—asthma	6.25e-05	0.000251	CcSEcCtD
Tadalafil—Loss of consciousness—Hydrocortisone—asthma	6.21e-05	0.00025	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—RHOA—asthma	6.2e-05	0.000821	CbGpPWpGaD
Tadalafil—Convulsion—Hydrocortisone—asthma	6.12e-05	0.000246	CcSEcCtD
Tadalafil—Nausea—Salbutamol—asthma	6.11e-05	0.000246	CcSEcCtD
Tadalafil—Hypertension—Hydrocortisone—asthma	6.1e-05	0.000245	CcSEcCtD
Tadalafil—Discomfort—Prednisolone—asthma	6.08e-05	0.000245	CcSEcCtD
Tadalafil—Angioedema—Triamcinolone—asthma	6.08e-05	0.000245	CcSEcCtD
Tadalafil—Haemoglobin—Prednisone—asthma	6.07e-05	0.000244	CcSEcCtD
Tadalafil—Angioedema—Methylprednisolone—asthma	6.07e-05	0.000244	CcSEcCtD
Tadalafil—Haemorrhage—Prednisone—asthma	6.04e-05	0.000243	CcSEcCtD
Tadalafil—Myalgia—Hydrocortisone—asthma	6.01e-05	0.000242	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—CD86—asthma	5.99e-05	0.000794	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CXCL8—asthma	5.99e-05	0.000794	CbGpPWpGaD
Tadalafil—Vertigo—Triamcinolone—asthma	5.98e-05	0.00024	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	5.97e-05	0.00024	CcSEcCtD
Tadalafil—Syncope—Triamcinolone—asthma	5.97e-05	0.00024	CcSEcCtD
Tadalafil—Vertigo—Methylprednisolone—asthma	5.96e-05	0.00024	CcSEcCtD
Tadalafil—Syncope—Methylprednisolone—asthma	5.95e-05	0.000239	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—EDN1—asthma	5.95e-05	0.000788	CbGpPWpGaD
Tadalafil—Discomfort—Hydrocortisone—asthma	5.94e-05	0.000239	CcSEcCtD
Tadalafil—Connective tissue disorder—Prednisone—asthma	5.93e-05	0.000239	CcSEcCtD
Tadalafil—Nausea—Budesonide—asthma	5.92e-05	0.000238	CcSEcCtD
Tadalafil—Oedema—Prednisolone—asthma	5.9e-05	0.000237	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—CCL5—asthma	5.9e-05	0.000782	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PLA2G4A—asthma	5.88e-05	0.000779	CbGpPWpGaD
Tadalafil—Loss of consciousness—Triamcinolone—asthma	5.85e-05	0.000235	CcSEcCtD
Tadalafil—Loss of consciousness—Methylprednisolone—asthma	5.83e-05	0.000235	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—CSF2—asthma	5.81e-05	0.00077	CbGpPWpGaD
Tadalafil—Shock—Prednisolone—asthma	5.81e-05	0.000234	CcSEcCtD
Tadalafil—Cough—Triamcinolone—asthma	5.81e-05	0.000233	CcSEcCtD
Tadalafil—Oedema—Hydrocortisone—asthma	5.77e-05	0.000232	CcSEcCtD
Tadalafil—Convulsion—Triamcinolone—asthma	5.76e-05	0.000232	CcSEcCtD
Tadalafil—Tachycardia—Prednisolone—asthma	5.76e-05	0.000232	CcSEcCtD
Tadalafil—Convulsion—Methylprednisolone—asthma	5.75e-05	0.000231	CcSEcCtD
Tadalafil—Hypertension—Triamcinolone—asthma	5.74e-05	0.000231	CcSEcCtD
Tadalafil—Hypertension—Methylprednisolone—asthma	5.73e-05	0.000231	CcSEcCtD
Tadalafil—Infection—Hydrocortisone—asthma	5.73e-05	0.00023	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—IL2—asthma	5.72e-05	0.000759	CbGpPWpGaD
Tadalafil—Hyperhidrosis—Prednisolone—asthma	5.71e-05	0.00023	CcSEcCtD
Tadalafil—Shock—Hydrocortisone—asthma	5.67e-05	0.000228	CcSEcCtD
Tadalafil—CYP3A4—Biological oxidations—ALDH2—asthma	5.67e-05	0.000752	CbGpPWpGaD
Tadalafil—Myalgia—Triamcinolone—asthma	5.66e-05	0.000228	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—SMAD3—asthma	5.66e-05	0.00075	CbGpPWpGaD
Tadalafil—Nervous system disorder—Hydrocortisone—asthma	5.65e-05	0.000227	CcSEcCtD
Tadalafil—Arthralgia—Methylprednisolone—asthma	5.65e-05	0.000227	CcSEcCtD
Tadalafil—Myalgia—Methylprednisolone—asthma	5.65e-05	0.000227	CcSEcCtD
Tadalafil—Eye disorder—Prednisone—asthma	5.64e-05	0.000227	CcSEcCtD
Tadalafil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—asthma	5.64e-05	0.000748	CbGpPWpGaD
Tadalafil—Tachycardia—Hydrocortisone—asthma	5.63e-05	0.000226	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	5.61e-05	0.000226	CcSEcCtD
Tadalafil—Flushing—Prednisone—asthma	5.6e-05	0.000225	CcSEcCtD
Tadalafil—Skin disorder—Hydrocortisone—asthma	5.6e-05	0.000225	CcSEcCtD
Tadalafil—Discomfort—Triamcinolone—asthma	5.6e-05	0.000225	CcSEcCtD
Tadalafil—Discomfort—Methylprednisolone—asthma	5.58e-05	0.000225	CcSEcCtD
Tadalafil—Hyperhidrosis—Hydrocortisone—asthma	5.57e-05	0.000224	CcSEcCtD
Tadalafil—Dry mouth—Triamcinolone—asthma	5.54e-05	0.000223	CcSEcCtD
Tadalafil—Angioedema—Betamethasone—asthma	5.52e-05	0.000222	CcSEcCtD
Tadalafil—Angioedema—Dexamethasone—asthma	5.52e-05	0.000222	CcSEcCtD
Tadalafil—Angiopathy—Prednisone—asthma	5.48e-05	0.00022	CcSEcCtD
Tadalafil—Immune system disorder—Prednisone—asthma	5.45e-05	0.000219	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—CXCL8—asthma	5.44e-05	0.000721	CbGpPWpGaD
Tadalafil—Oedema—Triamcinolone—asthma	5.43e-05	0.000218	CcSEcCtD
Tadalafil—Vertigo—Dexamethasone—asthma	5.42e-05	0.000218	CcSEcCtD
Tadalafil—Vertigo—Betamethasone—asthma	5.42e-05	0.000218	CcSEcCtD
Tadalafil—Syncope—Betamethasone—asthma	5.41e-05	0.000218	CcSEcCtD
Tadalafil—Syncope—Dexamethasone—asthma	5.41e-05	0.000218	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—PPP2CA—asthma	5.41e-05	0.000717	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GSTT1—asthma	5.4e-05	0.000715	CbGpPWpGaD
Tadalafil—Infection—Triamcinolone—asthma	5.39e-05	0.000217	CcSEcCtD
Tadalafil—Hypotension—Hydrocortisone—asthma	5.39e-05	0.000217	CcSEcCtD
Tadalafil—Infection—Methylprednisolone—asthma	5.38e-05	0.000216	CcSEcCtD
Tadalafil—Shock—Triamcinolone—asthma	5.34e-05	0.000215	CcSEcCtD
Tadalafil—Insomnia—Prednisolone—asthma	5.34e-05	0.000215	CcSEcCtD
Tadalafil—Shock—Methylprednisolone—asthma	5.33e-05	0.000214	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—CCR5—asthma	5.31e-05	0.000705	CbGpPWpGaD
Tadalafil—Nervous system disorder—Methylprednisolone—asthma	5.31e-05	0.000214	CcSEcCtD
Tadalafil—Loss of consciousness—Dexamethasone—asthma	5.31e-05	0.000213	CcSEcCtD
Tadalafil—Loss of consciousness—Betamethasone—asthma	5.31e-05	0.000213	CcSEcCtD
Tadalafil—Paraesthesia—Prednisolone—asthma	5.3e-05	0.000213	CcSEcCtD
Tadalafil—Tachycardia—Triamcinolone—asthma	5.3e-05	0.000213	CcSEcCtD
Tadalafil—Mental disorder—Prednisone—asthma	5.29e-05	0.000213	CcSEcCtD
Tadalafil—Tachycardia—Methylprednisolone—asthma	5.29e-05	0.000213	CcSEcCtD
Tadalafil—Skin disorder—Methylprednisolone—asthma	5.26e-05	0.000212	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Hydrocortisone—asthma	5.25e-05	0.000211	CcSEcCtD
Tadalafil—Hyperhidrosis—Triamcinolone—asthma	5.25e-05	0.000211	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—IL2RA—asthma	5.24e-05	0.000694	CbGpPWpGaD
Tadalafil—Hyperhidrosis—Methylprednisolone—asthma	5.24e-05	0.000211	CcSEcCtD
Tadalafil—Convulsion—Betamethasone—asthma	5.23e-05	0.00021	CcSEcCtD
Tadalafil—Convulsion—Dexamethasone—asthma	5.23e-05	0.00021	CcSEcCtD
Tadalafil—Insomnia—Hydrocortisone—asthma	5.22e-05	0.00021	CcSEcCtD
Tadalafil—Hypertension—Dexamethasone—asthma	5.21e-05	0.00021	CcSEcCtD
Tadalafil—Hypertension—Betamethasone—asthma	5.21e-05	0.00021	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—IL2—asthma	5.2e-05	0.000689	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—C3—asthma	5.19e-05	0.000688	CbGpPWpGaD
Tadalafil—Paraesthesia—Hydrocortisone—asthma	5.18e-05	0.000208	CcSEcCtD
Tadalafil—Myalgia—Dexamethasone—asthma	5.14e-05	0.000207	CcSEcCtD
Tadalafil—Myalgia—Betamethasone—asthma	5.14e-05	0.000207	CcSEcCtD
Tadalafil—Discomfort—Dexamethasone—asthma	5.08e-05	0.000204	CcSEcCtD
Tadalafil—Discomfort—Betamethasone—asthma	5.08e-05	0.000204	CcSEcCtD
Tadalafil—Dyspepsia—Hydrocortisone—asthma	5.08e-05	0.000204	CcSEcCtD
Tadalafil—Hypotension—Methylprednisolone—asthma	5.06e-05	0.000204	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—PDGFB—asthma	5.06e-05	0.00067	CbGpPWpGaD
Tadalafil—Pain—Prednisolone—asthma	5.05e-05	0.000203	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Hydrocortisone—asthma	4.98e-05	0.0002	CcSEcCtD
Tadalafil—Fatigue—Hydrocortisone—asthma	4.97e-05	0.0002	CcSEcCtD
Tadalafil—Vision blurred—Prednisone—asthma	4.95e-05	0.000199	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Triamcinolone—asthma	4.95e-05	0.000199	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Methylprednisolone—asthma	4.94e-05	0.000199	CcSEcCtD
Tadalafil—Pain—Hydrocortisone—asthma	4.93e-05	0.000198	CcSEcCtD
Tadalafil—Oedema—Dexamethasone—asthma	4.93e-05	0.000198	CcSEcCtD
Tadalafil—Oedema—Betamethasone—asthma	4.93e-05	0.000198	CcSEcCtD
Tadalafil—Insomnia—Triamcinolone—asthma	4.91e-05	0.000198	CcSEcCtD
Tadalafil—Insomnia—Methylprednisolone—asthma	4.9e-05	0.000197	CcSEcCtD
Tadalafil—Infection—Dexamethasone—asthma	4.89e-05	0.000197	CcSEcCtD
Tadalafil—Infection—Betamethasone—asthma	4.89e-05	0.000197	CcSEcCtD
Tadalafil—Paraesthesia—Triamcinolone—asthma	4.88e-05	0.000196	CcSEcCtD
Tadalafil—Paraesthesia—Methylprednisolone—asthma	4.86e-05	0.000196	CcSEcCtD
Tadalafil—Shock—Dexamethasone—asthma	4.85e-05	0.000195	CcSEcCtD
Tadalafil—Shock—Betamethasone—asthma	4.85e-05	0.000195	CcSEcCtD
Tadalafil—Dyspnoea—Triamcinolone—asthma	4.84e-05	0.000195	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—LEP—asthma	4.84e-05	0.000641	CbGpPWpGaD
Tadalafil—Nervous system disorder—Dexamethasone—asthma	4.83e-05	0.000194	CcSEcCtD
Tadalafil—Nervous system disorder—Betamethasone—asthma	4.83e-05	0.000194	CcSEcCtD
Tadalafil—Tachycardia—Dexamethasone—asthma	4.81e-05	0.000193	CcSEcCtD
Tadalafil—Tachycardia—Betamethasone—asthma	4.81e-05	0.000193	CcSEcCtD
Tadalafil—Angioedema—Prednisone—asthma	4.8e-05	0.000193	CcSEcCtD
Tadalafil—Dyspepsia—Triamcinolone—asthma	4.78e-05	0.000192	CcSEcCtD
Tadalafil—Dyspepsia—Methylprednisolone—asthma	4.77e-05	0.000192	CcSEcCtD
Tadalafil—Hyperhidrosis—Dexamethasone—asthma	4.76e-05	0.000192	CcSEcCtD
Tadalafil—Hyperhidrosis—Betamethasone—asthma	4.76e-05	0.000192	CcSEcCtD
Tadalafil—Vertigo—Prednisone—asthma	4.72e-05	0.00019	CcSEcCtD
Tadalafil—Gastrointestinal pain—Hydrocortisone—asthma	4.72e-05	0.00019	CcSEcCtD
Tadalafil—Syncope—Prednisone—asthma	4.71e-05	0.00019	CcSEcCtD
Tadalafil—Urticaria—Prednisolone—asthma	4.69e-05	0.000189	CcSEcCtD
Tadalafil—Fatigue—Triamcinolone—asthma	4.68e-05	0.000188	CcSEcCtD
Tadalafil—Fatigue—Methylprednisolone—asthma	4.67e-05	0.000188	CcSEcCtD
Tadalafil—Pain—Triamcinolone—asthma	4.64e-05	0.000187	CcSEcCtD
Tadalafil—Loss of consciousness—Prednisone—asthma	4.62e-05	0.000186	CcSEcCtD
Tadalafil—Hypotension—Betamethasone—asthma	4.6e-05	0.000185	CcSEcCtD
Tadalafil—Hypotension—Dexamethasone—asthma	4.6e-05	0.000185	CcSEcCtD
Tadalafil—Urticaria—Hydrocortisone—asthma	4.58e-05	0.000184	CcSEcCtD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—asthma	4.57e-05	0.000606	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—FN1—asthma	4.56e-05	0.000604	CbGpPWpGaD
Tadalafil—Abdominal pain—Hydrocortisone—asthma	4.56e-05	0.000183	CcSEcCtD
Tadalafil—Convulsion—Prednisone—asthma	4.55e-05	0.000183	CcSEcCtD
Tadalafil—Hypertension—Prednisone—asthma	4.54e-05	0.000183	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Dexamethasone—asthma	4.49e-05	0.000181	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Betamethasone—asthma	4.49e-05	0.000181	CcSEcCtD
Tadalafil—Myalgia—Prednisone—asthma	4.48e-05	0.00018	CcSEcCtD
Tadalafil—Arthralgia—Prednisone—asthma	4.48e-05	0.00018	CcSEcCtD
Tadalafil—Insomnia—Dexamethasone—asthma	4.46e-05	0.000179	CcSEcCtD
Tadalafil—Insomnia—Betamethasone—asthma	4.46e-05	0.000179	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	4.44e-05	0.000179	CcSEcCtD
Tadalafil—Gastrointestinal pain—Methylprednisolone—asthma	4.43e-05	0.000178	CcSEcCtD
Tadalafil—Paraesthesia—Betamethasone—asthma	4.42e-05	0.000178	CcSEcCtD
Tadalafil—Paraesthesia—Dexamethasone—asthma	4.42e-05	0.000178	CcSEcCtD
Tadalafil—Discomfort—Prednisone—asthma	4.42e-05	0.000178	CcSEcCtD
Tadalafil—Hypersensitivity—Prednisolone—asthma	4.35e-05	0.000175	CcSEcCtD
Tadalafil—Dyspepsia—Dexamethasone—asthma	4.34e-05	0.000174	CcSEcCtD
Tadalafil—Dyspepsia—Betamethasone—asthma	4.34e-05	0.000174	CcSEcCtD
Tadalafil—Urticaria—Triamcinolone—asthma	4.31e-05	0.000173	CcSEcCtD
Tadalafil—Urticaria—Methylprednisolone—asthma	4.3e-05	0.000173	CcSEcCtD
Tadalafil—Oedema—Prednisone—asthma	4.29e-05	0.000173	CcSEcCtD
Tadalafil—Abdominal pain—Methylprednisolone—asthma	4.28e-05	0.000172	CcSEcCtD
Tadalafil—Infection—Prednisone—asthma	4.26e-05	0.000171	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Dexamethasone—asthma	4.25e-05	0.000171	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Betamethasone—asthma	4.25e-05	0.000171	CcSEcCtD
Tadalafil—Hypersensitivity—Hydrocortisone—asthma	4.25e-05	0.000171	CcSEcCtD
Tadalafil—Fatigue—Dexamethasone—asthma	4.25e-05	0.000171	CcSEcCtD
Tadalafil—Fatigue—Betamethasone—asthma	4.25e-05	0.000171	CcSEcCtD
Tadalafil—Shock—Prednisone—asthma	4.22e-05	0.00017	CcSEcCtD
Tadalafil—Pain—Betamethasone—asthma	4.21e-05	0.000169	CcSEcCtD
Tadalafil—Pain—Dexamethasone—asthma	4.21e-05	0.000169	CcSEcCtD
Tadalafil—Nervous system disorder—Prednisone—asthma	4.21e-05	0.000169	CcSEcCtD
Tadalafil—Tachycardia—Prednisone—asthma	4.19e-05	0.000168	CcSEcCtD
Tadalafil—Skin disorder—Prednisone—asthma	4.17e-05	0.000168	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—POMC—asthma	4.15e-05	0.000551	CbGpPWpGaD
Tadalafil—Hyperhidrosis—Prednisone—asthma	4.15e-05	0.000167	CcSEcCtD
Tadalafil—Asthenia—Hydrocortisone—asthma	4.14e-05	0.000166	CcSEcCtD
Tadalafil—Pruritus—Hydrocortisone—asthma	4.08e-05	0.000164	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—CCL2—asthma	4.06e-05	0.000539	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IL6R—asthma	4.05e-05	0.000537	CbGpPWpGaD
Tadalafil—Gastrointestinal pain—Dexamethasone—asthma	4.03e-05	0.000162	CcSEcCtD
Tadalafil—Gastrointestinal pain—Betamethasone—asthma	4.03e-05	0.000162	CcSEcCtD
Tadalafil—Hypersensitivity—Triamcinolone—asthma	4e-05	0.000161	CcSEcCtD
Tadalafil—Hypersensitivity—Methylprednisolone—asthma	3.99e-05	0.000161	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—EGFR—asthma	3.98e-05	0.000527	CbGpPWpGaD
Tadalafil—Diarrhoea—Hydrocortisone—asthma	3.95e-05	0.000159	CcSEcCtD
Tadalafil—Urticaria—Betamethasone—asthma	3.91e-05	0.000157	CcSEcCtD
Tadalafil—Urticaria—Dexamethasone—asthma	3.91e-05	0.000157	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Prednisone—asthma	3.91e-05	0.000157	CcSEcCtD
Tadalafil—Dizziness—Prednisolone—asthma	3.9e-05	0.000157	CcSEcCtD
Tadalafil—Asthenia—Triamcinolone—asthma	3.9e-05	0.000157	CcSEcCtD
Tadalafil—Abdominal pain—Dexamethasone—asthma	3.89e-05	0.000157	CcSEcCtD
Tadalafil—Abdominal pain—Betamethasone—asthma	3.89e-05	0.000157	CcSEcCtD
Tadalafil—Asthenia—Methylprednisolone—asthma	3.89e-05	0.000156	CcSEcCtD
Tadalafil—Insomnia—Prednisone—asthma	3.88e-05	0.000156	CcSEcCtD
Tadalafil—Paraesthesia—Prednisone—asthma	3.85e-05	0.000155	CcSEcCtD
Tadalafil—Pruritus—Triamcinolone—asthma	3.84e-05	0.000155	CcSEcCtD
Tadalafil—Pruritus—Methylprednisolone—asthma	3.83e-05	0.000154	CcSEcCtD
Tadalafil—Dizziness—Hydrocortisone—asthma	3.81e-05	0.000153	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—SERPINE1—asthma	3.79e-05	0.000503	CbGpPWpGaD
Tadalafil—Dyspepsia—Prednisone—asthma	3.78e-05	0.000152	CcSEcCtD
Tadalafil—CYP3A4—Biological oxidations—GSTP1—asthma	3.74e-05	0.000496	CbGpPWpGaD
Tadalafil—Rash—Prednisolone—asthma	3.72e-05	0.00015	CcSEcCtD
Tadalafil—Dermatitis—Prednisolone—asthma	3.72e-05	0.00015	CcSEcCtD
Tadalafil—Diarrhoea—Methylprednisolone—asthma	3.71e-05	0.000149	CcSEcCtD
Tadalafil—Fatigue—Prednisone—asthma	3.7e-05	0.000149	CcSEcCtD
Tadalafil—Headache—Prednisolone—asthma	3.7e-05	0.000149	CcSEcCtD
Tadalafil—CYP3A4—Metapathway biotransformation—GSTP1—asthma	3.69e-05	0.000489	CbGpPWpGaD
Tadalafil—Constipation—Prednisone—asthma	3.67e-05	0.000148	CcSEcCtD
Tadalafil—Vomiting—Hydrocortisone—asthma	3.67e-05	0.000147	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—RHOA—asthma	3.66e-05	0.000485	CbGpPWpGaD
Tadalafil—Rash—Hydrocortisone—asthma	3.64e-05	0.000146	CcSEcCtD
Tadalafil—Dermatitis—Hydrocortisone—asthma	3.63e-05	0.000146	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—NOS3—asthma	3.62e-05	0.00048	CbGpPWpGaD
Tadalafil—Headache—Hydrocortisone—asthma	3.61e-05	0.000145	CcSEcCtD
Tadalafil—Dizziness—Triamcinolone—asthma	3.59e-05	0.000144	CcSEcCtD
Tadalafil—Dizziness—Methylprednisolone—asthma	3.58e-05	0.000144	CcSEcCtD
Tadalafil—Asthenia—Dexamethasone—asthma	3.53e-05	0.000142	CcSEcCtD
Tadalafil—Asthenia—Betamethasone—asthma	3.53e-05	0.000142	CcSEcCtD
Tadalafil—Gastrointestinal pain—Prednisone—asthma	3.51e-05	0.000141	CcSEcCtD
Tadalafil—Nausea—Prednisolone—asthma	3.51e-05	0.000141	CcSEcCtD
Tadalafil—Pruritus—Dexamethasone—asthma	3.49e-05	0.00014	CcSEcCtD
Tadalafil—Pruritus—Betamethasone—asthma	3.49e-05	0.00014	CcSEcCtD
Tadalafil—Vomiting—Triamcinolone—asthma	3.45e-05	0.000139	CcSEcCtD
Tadalafil—Vomiting—Methylprednisolone—asthma	3.44e-05	0.000139	CcSEcCtD
Tadalafil—CYP3A4—Biological oxidations—GSTM1—asthma	3.44e-05	0.000456	CbGpPWpGaD
Tadalafil—Nausea—Hydrocortisone—asthma	3.43e-05	0.000138	CcSEcCtD
Tadalafil—Rash—Triamcinolone—asthma	3.42e-05	0.000138	CcSEcCtD
Tadalafil—Dermatitis—Triamcinolone—asthma	3.42e-05	0.000138	CcSEcCtD
Tadalafil—Rash—Methylprednisolone—asthma	3.42e-05	0.000137	CcSEcCtD
Tadalafil—Dermatitis—Methylprednisolone—asthma	3.41e-05	0.000137	CcSEcCtD
Tadalafil—Urticaria—Prednisone—asthma	3.41e-05	0.000137	CcSEcCtD
Tadalafil—Headache—Triamcinolone—asthma	3.4e-05	0.000137	CcSEcCtD
Tadalafil—Headache—Methylprednisolone—asthma	3.39e-05	0.000137	CcSEcCtD
Tadalafil—Abdominal pain—Prednisone—asthma	3.39e-05	0.000136	CcSEcCtD
Tadalafil—CYP3A4—Metapathway biotransformation—GSTM1—asthma	3.39e-05	0.000449	CbGpPWpGaD
Tadalafil—Diarrhoea—Dexamethasone—asthma	3.37e-05	0.000136	CcSEcCtD
Tadalafil—Diarrhoea—Betamethasone—asthma	3.37e-05	0.000136	CcSEcCtD
Tadalafil—Dizziness—Betamethasone—asthma	3.26e-05	0.000131	CcSEcCtD
Tadalafil—Dizziness—Dexamethasone—asthma	3.26e-05	0.000131	CcSEcCtD
Tadalafil—Nausea—Triamcinolone—asthma	3.22e-05	0.00013	CcSEcCtD
Tadalafil—Nausea—Methylprednisolone—asthma	3.22e-05	0.000129	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—CXCL8—asthma	3.21e-05	0.000426	CbGpPWpGaD
Tadalafil—Hypersensitivity—Prednisone—asthma	3.16e-05	0.000127	CcSEcCtD
Tadalafil—Vomiting—Betamethasone—asthma	3.13e-05	0.000126	CcSEcCtD
Tadalafil—Vomiting—Dexamethasone—asthma	3.13e-05	0.000126	CcSEcCtD
Tadalafil—Rash—Betamethasone—asthma	3.11e-05	0.000125	CcSEcCtD
Tadalafil—Rash—Dexamethasone—asthma	3.11e-05	0.000125	CcSEcCtD
Tadalafil—Dermatitis—Dexamethasone—asthma	3.1e-05	0.000125	CcSEcCtD
Tadalafil—Dermatitis—Betamethasone—asthma	3.1e-05	0.000125	CcSEcCtD
Tadalafil—Headache—Dexamethasone—asthma	3.09e-05	0.000124	CcSEcCtD
Tadalafil—Headache—Betamethasone—asthma	3.09e-05	0.000124	CcSEcCtD
Tadalafil—Asthenia—Prednisone—asthma	3.08e-05	0.000124	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—IL2—asthma	3.07e-05	0.000407	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—IL6—asthma	3.06e-05	0.000405	CbGpPWpGaD
Tadalafil—Pruritus—Prednisone—asthma	3.04e-05	0.000122	CcSEcCtD
Tadalafil—Diarrhoea—Prednisone—asthma	2.94e-05	0.000118	CcSEcCtD
Tadalafil—Nausea—Dexamethasone—asthma	2.93e-05	0.000118	CcSEcCtD
Tadalafil—Nausea—Betamethasone—asthma	2.93e-05	0.000118	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—MMP9—asthma	2.91e-05	0.000385	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PTEN—asthma	2.89e-05	0.000383	CbGpPWpGaD
Tadalafil—Dizziness—Prednisone—asthma	2.84e-05	0.000114	CcSEcCtD
Tadalafil—Vomiting—Prednisone—asthma	2.73e-05	0.00011	CcSEcCtD
Tadalafil—Rash—Prednisone—asthma	2.71e-05	0.000109	CcSEcCtD
Tadalafil—Dermatitis—Prednisone—asthma	2.7e-05	0.000109	CcSEcCtD
Tadalafil—Headache—Prednisone—asthma	2.69e-05	0.000108	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—VEGFA—asthma	2.61e-05	0.000346	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—STAT3—asthma	2.58e-05	0.000343	CbGpPWpGaD
Tadalafil—Nausea—Prednisone—asthma	2.55e-05	0.000103	CcSEcCtD
Tadalafil—CYP3A4—Biological oxidations—POMC—asthma	2.43e-05	0.000322	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TGFB1—asthma	2.4e-05	0.000318	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—EGFR—asthma	2.35e-05	0.000311	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—LTC4S—asthma	2.29e-05	0.000304	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—LTA4H—asthma	1.99e-05	0.000263	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IL6—asthma	1.8e-05	0.000239	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ARG1—asthma	1.74e-05	0.00023	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALDH7A1—asthma	1.57e-05	0.000208	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ARG2—asthma	1.51e-05	0.0002	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALOX5AP—asthma	1.25e-05	0.000165	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALOX15—asthma	1.25e-05	0.000165	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CHAT—asthma	1.19e-05	0.000158	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALOX5—asthma	1.06e-05	0.000141	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CARM1—asthma	1.01e-05	0.000134	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—DCN—asthma	9.97e-06	0.000132	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALDH2—asthma	9.7e-06	0.000129	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTT1—asthma	9.23e-06	0.000122	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—NQO1—asthma	7.67e-06	0.000102	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ADCY2—asthma	7.5e-06	9.95e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTP1—asthma	6.4e-06	8.48e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HMOX1—asthma	6.31e-06	8.36e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ITPR1—asthma	6.29e-06	8.34e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CAT—asthma	6.22e-06	8.25e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PLA2G4A—asthma	5.88e-06	7.79e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTM1—asthma	5.88e-06	7.79e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PPP2CA—asthma	5.41e-06	7.18e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—POMC—asthma	4.15e-06	5.51e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALB—asthma	3.79e-06	5.02e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—NOS3—asthma	3.62e-06	4.8e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PTGS2—asthma	3.31e-06	4.39e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PTEN—asthma	2.89e-06	3.83e-05	CbGpPWpGaD
